-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ALYN3W48OhLXVfNwmwPvqTcropmrC380KR9Dtffa2DC7YlG979pJS/LwE1J4k/aU ucbaaVaDd/xUiM5vTIp/sg== 0000889812-99-002132.txt : 19990715 0000889812-99-002132.hdr.sgml : 19990715 ACCESSION NUMBER: 0000889812-99-002132 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990714 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EPOCH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910057 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911311592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-42701 FILM NUMBER: 99664243 BUSINESS ADDRESS: STREET 1: 12277 134TH COURT NE STREET 2: #110 CITY: REDMOND STATE: WA ZIP: 98052 BUSINESS PHONE: 425-821-7535 MAIL ADDRESS: STREET 1: 12277 134TH COURT NE STREET 2: #110 CITY: REDMOND STATE: WA ZIP: 98052 FORMER COMPANY: FORMER CONFORMED NAME: MICROPROBE CORP /DE/ DATE OF NAME CHANGE: 19930730 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JESSELSON MICHAEL G CENTRAL INDEX KEY: 0000945191 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 1301 AVE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10019 MAIL ADDRESS: STREET 1: 1301 AVENUE OF THE AMERICAS STREET 2: SUITE 4101 CITY: NEW YORK STATE: NY ZIP: 10019 SC 13D/A 1 AMENDMENT NO. 1 TO STATEMENT OF BENEFICIAL OWNERSHIP SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------------- SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* EPOCH PHARMACEUTICALS, INC. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 294273 10 7 (CUSIP Number) Michael G. Jesselson Suite 4101 1301 Avenue of the Americas New York, NY 10019 212-459-9517 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 1996 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement of Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. NOTE: Six copies of this statement, including all exhibits should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 4 Pages) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Schedule 13D CUSIP NO. 294273 10 7 PAGE 2 OF 4 PAGES 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Michael G. Jesselson 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. SOURCE OF FUNDS* 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] 6. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. 7. SOLE VOTING POWER NUMBER OF 482,500 SHARES BENEFICIALLY 8. SHARED VOTING POWER OWNED BY -0- EACH REPORTING 9. SOLE DISPOSITIVE POWER PERSON WITH 482,500 10. SHARED DISPOSITIVE POWER -0- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 482,500 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.2% 14. TYPE OF REPORTING PERSON* IN *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 3 of 4 Pages This statement constitutes Amendment No. 1 to the statement on Schedule 13D filed with the Securities and Exchange Commission on May 10, 1995 (the "Original Statement"), of Michael G. Jesselson. All defined terms hereunder have the meanings set forth in the Original Statement. This Amendment No. 1 reflects certain material changes in the information set forth in the Original Statement, as follows: Item 5. Interest in Securities of the Issuer. (e) In October 1996, Mr. Jesselson ceased to be the beneficial owner of more than 5% of the Company's Common Stock due to issuances of additional Common Stock by the Company. PAGE 4 OF 4 PAGES SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. July 14, 1999 /s/ Michael G. Jesselson ------------------------- Michael G. Jesselson -----END PRIVACY-ENHANCED MESSAGE-----